Breaking News Instant updates and real-time market news.

DVAX

Dynavax

$12.90

-0.1 (-0.77%)

07:33
08/07/18
08/07
07:33
08/07/18
07:33

Dynavax price target raised to $30 from $27 at Cantor Fitzgerald

Cantor Fitzgerald analyst Elemer Piros raised his price target for Dynavax Technologies to $30 and reiterates an Overweight rating on the shares following the company's Q2 results. The analyst believes there are a "number of opportunities in the near future for Dynavax that could lead to upside for the company," including future Heplisav-B vaccine sales and a Phase 3 trial initiation for SD-101 in advanced melanoma.

DVAX Dynavax
$12.90

-0.1 (-0.77%)

04/17/18
WBLR
04/17/18
NO CHANGE
WBLR
Outperform
William Blair says SD-101 not in $40 fair estimate for Dynavax shares
Dynavax Technologies' data thus far in squamous cell carcinoma of the head and neck and melanoma are "compelling" and will see SD-101 "finally getting into" the stock as the Street comes to appreciate the oncology side of the business, William Blair analyst Y. Katherine Xu tells investors in a research note. She points out that SD-101, or Dynavax's other oncology assets, are not included in her $40 fair value estimate of the stock. These opportunities represent "significant upside to our valuation," Xu contends. The analyst keeps an Outperform rating on Dynavax. The stock closed yesterday at $18.85.
05/10/18
JPMS
05/10/18
UPGRADE
Target $27
JPMS
Overweight
Dynavax upgraded to Overweight from Neutral at JPMorgan
JPMorgan analyst Anupam Rama upgraded Dynavax Technologies to Overweight and raised his price target for the shares to $27 from $25 following the company's Q1 results. The analyst believes TLR9 agonist SD-101 is an underappreciated asset.
05/10/18
JPMS
05/10/18
UPGRADE
Target $27
JPMS
Overweight
JPMorgan upgrades Dynavax on 'vastly underappreciated' SD-101
JPMorgan analyst Anupam Rama upgraded Dynavax Technologies to Overweight from Neutral and raised his price target for the shares to $27 from $25. While a Heplisav launch inflection in 2019 is widely expected, the company's SD-101 opportunity is being "vastly underappreciated" at current share levels, Rama tells investors in a research note. SD-101 has shown encouraging early signals of efficacy in both the melanoma and head and neck indications, the analyst contends. Rama points out that a Phase 2 melanoma update is expected next month at ASCO. He likes the stocks' reward/risk profile going into the readout. The analyst sees 30%-60% upside potential versus 0%-10% downside risk on the data.
05/17/18
JPMS
05/17/18
NO CHANGE
JPMS
Overweight
Dynavax should trade to $21-$22 on abstract data, says JPMorgan
JPMorgan analyst Anupam Rama believes shares of Dynavax should trade up 5%-15% to the $21-$22 range on the SD-101 melanoma ASCO abstract. While some on the Street were inappropriately setting the benchmark at 70%-80% overall response, the abstract data "very much put the early efficacy signals" of SD-101 plus pembrolizumab in the ballpark of nivolumab plus ipilimumab from CHECKMATE-067, with a cleaner safety profile, Rama tells investors in a research note. He says the abstract met his "base case / win / upside scenario."

TODAY'S FREE FLY STORIES

FDX

FedEx

$156.00

-4.88 (-3.03%)

17:51
06/25/19
06/25
17:51
06/25/19
17:51
Hot Stocks
FedEx says has made no pricing changes »

Says business realignment…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 30

    Jul

  • 31

    Jul

  • 13

    Nov

FDX

FedEx

$156.00

-4.88 (-3.03%)

17:46
06/25/19
06/25
17:46
06/25/19
17:46
Hot Stocks
FedEx says international commercial team still poised for growth »

Says TNT Express…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 30

    Jul

  • 31

    Jul

  • 13

    Nov

FDX

FedEx

$156.00

-4.88 (-3.03%)

17:43
06/25/19
06/25
17:43
06/25/19
17:43
Hot Stocks
FedEx says global trade picture 'less than ideal' »

Says "all-in"…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 30

    Jul

  • 31

    Jul

  • 13

    Nov

FDX

FedEx

$156.00

-4.88 (-3.03%)

17:38
06/25/19
06/25
17:38
06/25/19
17:38
Hot Stocks
FedEx calls FY20 a 'transition year' »

Says FY20 a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 30

    Jul

  • 31

    Jul

  • 13

    Nov

FDX

FedEx

$156.00

-4.88 (-3.03%)

17:37
06/25/19
06/25
17:37
06/25/19
17:37
Hot Stocks
FedEx says intends to substantially grow e-commerce business »

Sees FedEx Freight will…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 30

    Jul

  • 31

    Jul

  • 13

    Nov

CNX

CNX Resources

$6.83

-0.345 (-4.81%)

17:36
06/25/19
06/25
17:36
06/25/19
17:36
Hot Stocks
CNX Resources director Bernard Lanigan purchases 36,200 shares of company stock »

CNX Resources director…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FTI

TechnipFMC

$24.96

0.21 (0.85%)

17:32
06/25/19
06/25
17:32
06/25/19
17:32
Hot Stocks
TechnipFMC confirms settlement with U.S., Brazilian enforcement authorities »

TechnipFMC has agreed to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 27

    Aug

MO

Altria Group

$48.80

0.31 (0.64%)

, BTI

British American Tobacco

$35.76

0.56 (1.59%)

17:25
06/25/19
06/25
17:25
06/25/19
17:25
Periodicals
San Francisco votes to ban sale of e-cigarettes, AP reports »

San Francisco, California…

MO

Altria Group

$48.80

0.31 (0.64%)

BTI

British American Tobacco

$35.76

0.56 (1.59%)

PM

Philip Morris

$78.85

1.02 (1.31%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVS

CVS Health

$53.69

0.57 (1.07%)

17:16
06/25/19
06/25
17:16
06/25/19
17:16
Recommendations
CVS Health analyst commentary at Tigress Financial »

Tigress Financial sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FTI

TechnipFMC

$24.96

0.21 (0.85%)

17:15
06/25/19
06/25
17:15
06/25/19
17:15
Hot Stocks
TechnipFMC, subsidiary to pay $296M to resolve foreign bribery charges »

TechnipFMC and its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 27

    Aug

ORRF

Orrstown Financial

$21.93

0.22 (1.01%)

17:11
06/25/19
06/25
17:11
06/25/19
17:11
Hot Stocks
Orrstown Financial names Thomas Brugger EVP and CFO »

Orrstown Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MU

Micron

$32.71

-0.47 (-1.42%)

17:07
06/25/19
06/25
17:07
06/25/19
17:07
Hot Stocks
Micron says it has mitigated 90% of China tariff impact »

Says U.S. tariffs on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 09

    Jul

AGN

Allergan

$162.60

32.95 (25.41%)

, ABBV

AbbVie

$65.63

-12.78 (-16.30%)

17:07
06/25/19
06/25
17:07
06/25/19
17:07
On The Fly
Fly Intel: Wall Street's top stories for Tuesday »

Stocks muddled through a…

AGN

Allergan

$162.60

32.95 (25.41%)

ABBV

AbbVie

$65.63

-12.78 (-16.30%)

TMUS

T-Mobile

$74.56

-0.98 (-1.30%)

S

Sprint

$6.82

-0.04 (-0.58%)

DISH

Dish

$37.80

-0.79 (-2.05%)

LEN

Lennar

$48.24

-3.17 (-6.17%)

FDX

FedEx

$156.00

-4.88 (-3.03%)

UPS

UPS

$97.11

-2.58 (-2.59%)

FB

Facebook

$188.87

-3.69 (-1.92%)

PYX

Pyxus

$17.06

3.635 (27.09%)

GRUB

GrubHub

$76.01

3.96 (5.50%)

ALDX

Aldeyra

$6.21

-0.87 (-12.29%)

W

Wayfair

$144.54

-7.925 (-5.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 25

    Jun

  • 25

    Jun

  • 25

    Jun

  • 25

    Jun

  • 26

    Jun

  • 27

    Jun

  • 27

    Jun

  • 28

    Jun

  • 09

    Jul

  • 10

    Jul

  • 16

    Jul

  • 24

    Jul

  • 30

    Jul

  • 31

    Jul

  • 16

    Sep

  • 13

    Nov

AITB

AIT Therapeutics

$5.33

0.06 (1.14%)

17:05
06/25/19
06/25
17:05
06/25/19
17:05
Hot Stocks
AIT Therapeutics plans to file PMA submission with FDA for PPHN with AirNOvent »

On track to file a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MU

Micron

$32.71

-0.47 (-1.42%)

17:03
06/25/19
06/25
17:03
06/25/19
17:03
Earnings
Micron sees Q4 EPS 45c +/- 7c, consensus 78c »

Sees Q4 revenue $4.5B +/-…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 09

    Jul

AITB

AIT Therapeutics

$5.33

0.06 (1.14%)

17:00
06/25/19
06/25
17:00
06/25/19
17:00
Earnings
AIT Therapeutics reports Q4 EPS (49c), consensus 28c »

Reports Q4 revenue $7.7M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MU

Micron

$32.71

-0.47 (-1.42%)

16:48
06/25/19
06/25
16:48
06/25/19
16:48
Hot Stocks
Micron says it can resume shipping a certain subset of products to Huawei »

Says expects healthy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 09

    Jul

AVAV

AeroVironment

$61.41

-0.52 (-0.84%)

16:42
06/25/19
06/25
16:42
06/25/19
16:42
Hot Stocks
AeroVironment down 9.5% to $55.50 after Q4 results, FY20 guidance »

The midpoint of the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

BBVA

Banco Bilbao

$5.52

-0.05 (-0.90%)

16:40
06/25/19
06/25
16:40
06/25/19
16:40
Syndicate
Breaking Syndicate news story on Banco Bilbao »

Banco Bilbao files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

CRTO

Criteo

$18.00

-0.05 (-0.28%)

16:39
06/25/19
06/25
16:39
06/25/19
16:39
Hot Stocks
Criteo COO Mollie Spilman to leave company »

Criteo S.A. announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KHC

Kraft Heinz

$30.68

0.17 (0.56%)

16:37
06/25/19
06/25
16:37
06/25/19
16:37
Hot Stocks
Kraft Heinz accelerates new CEO start date to June 25 »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPOT

Spotify

$144.12

-5.99 (-3.99%)

16:34
06/25/19
06/25
16:34
06/25/19
16:34
Periodicals
Spotify chief revenue officer Brian Benedik to depart, The Information reports »

Spotify's chief…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:34
06/25/19
06/25
16:34
06/25/19
16:34
General news
API crude inventories for week of June 21 »

API reports that crude…

GBCI

Glacier Bancorp

$39.23

-0.06 (-0.15%)

16:34
06/25/19
06/25
16:34
06/25/19
16:34
Hot Stocks
Glacier Bancorp raises dividend to 27c from 26c »

Glacier Bancorp declared…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

NSRGY

Nestle

$0.00

(0.00%)

, NVS

Novartis

$92.37

-0.41 (-0.44%)

16:33
06/25/19
06/25
16:33
06/25/19
16:33
Periodicals
Nestle, Novartis among multinationals at risk of London trading ban, WSJ says »

Trading in…

NSRGY

Nestle

$0.00

(0.00%)

NVS

Novartis

$92.37

-0.41 (-0.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.